Abbott Laboratories (TSX:ABT)

Abbott Laboratories Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 22, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	289,900	298,710	282,278	252,356	259,081	305,445
Market Cap Growth	1.56%	5.82%	11.86%	-2.60%	-15.18%	27.78%
Enterprise Value	297,567	306,323	293,055	264,064	268,395	316,734
Last Close Price	21.45	22.29	-	-	-	-
PE Ratio	32.41	33.39	14.69	33.52	27.72	34.28
PS Ratio	4.77	4.92	4.68	4.76	4.39	5.60
PB Ratio	4.12	4.25	4.10	4.92	5.19	6.70
P/TBV Ratio	9.89	10.19	10.96	31.28	55.76	-
P/FCF Ratio	-	-	30.89	37.77	24.53	27.91
P/OCF Ratio	-	-	22.92	26.32	19.98	22.92
EV/Sales Ratio	4.86	5.04	4.86	4.99	4.54	5.81
EV/EBITDA Ratio	19.32	20.03	19.01	19.11	16.02	19.64
EV/EBIT Ratio	26.76	27.74	27.17	27.69	21.76	27.19
EV/FCF Ratio	-	-	32.07	39.52	25.41	28.94
Debt / Equity Ratio	0.25	0.25	0.32	0.41	0.49	0.53
Debt / EBITDA Ratio	1.16	1.16	1.38	1.48	1.41	1.47
Debt / FCF Ratio	-	-	2.41	3.16	2.30	2.23
Asset Turnover	-	-	0.54	0.54	0.58	0.58
Inventory Turnover	-	-	2.92	2.81	3.37	3.56
Quick Ratio	-	-	1.05	1.00	1.06	1.28
Current Ratio	-	-	1.67	1.64	1.63	1.85
Return on Equity (ROE)	13.16%	13.16%	30.91%	15.11%	19.01%	20.49%
Return on Assets (ROA)	-	-	6.06%	6.11%	7.61%	7.79%
Return on Invested Capital (ROIC)	10.98%	11.11%	14.59%	13.45%	16.96%	17.46%
Return on Capital Employed (ROCE)	-	-	11.10%	12.20%	15.50%	14.80%
Earnings Yield	3.09%	3.00%	6.83%	3.00%	3.62%	2.93%
FCF Yield	-	-	3.24%	2.65%	4.08%	3.58%
Payout Ratio	-	-	28.62%	62.13%	47.73%	45.28%
Buyback Yield / Dilution	-0.06%	-0.06%	0.06%	0.85%	1.40%	-0.17%
Total Shareholder Return	-0.06%	-0.06%	0.06%	0.85%	1.40%	-0.17%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.